Extracellular vesicles derived from adipose-derived mesenchymal stem/stromal cells prevent synovial inflammation and attenuate cartilage degeneration in rodent osteoarthritis
Regenerative Therapy · 2026-03 · 31 · 101056
DOI: 10.1016/j.reth.2025.101056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Therapy, 2026-03. Verfasst von Yushi Maruiwa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Keio University School of Medicine, Keio University, Tokyo, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Keio University, School of Medicine, Keio University.
Abstract (Originalsprache)
Objective
Osteoarthritis (OA) is the most common joint disease in the elderly and a major cause of pain and disability. Recent advances in OA therapy have led to a greater variety of treatment options. Extracellular vesicles (EVs) have recently emerged as a potential therapeutic approach for OA. This study aimed to demonstrate the disease-modifying effects of adipose-derived mesenchymal stem cell-derived EVs (MSC-EVs) on OA.
Methods
The anti-inflammatory effects of MSC-EVs were evaluated using RAW264.7 macrophage-like cells stimulated with lipopolysaccharide and human synovial cells stimulated with IL-1β. In vivo, MSC-EVs were administered intra-articularly into knees of rats with monosodium iodoacetate (MIA)-induced OA. Pain thresholds, gait parameters, histological scores, and cytokine levels were assessed. Single-cell RNA sequencing (scRNA-seq) was performed on joint tissues to evaluate cell-specific gene expression and macrophage polarization.
Results
In vitro, MSC-EVs reduced the mRNA expression of IL-1β and IL-6 in RAW264.7 cells, and significantly suppressed multiple inflammatory cytokines while upregulating FGF-18 in synovial cells. In vivo, intra-articular MSC-EV injection increased pain threshold, improved gait, and reduced synovial inflammation and cartilage degeneration. scRNA-seq revealed decreased inflammatory cytokines, increased PRG4 and FGF-18 expression, and a shift in macrophage polarization toward an M2 phenotype in the EV-treated group.
Conclusion
MSC-EVs exert anti-inflammatory and cartilage-protective effects in OA through immune modulation and regenerative signaling, indicating their significant therapeutic potential as a disease-modifying strategy for OA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Keio University School of Medicine, Keio University, Tokyo, Japan.
- Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Tokyo, Japan.
- Biomedical Laboratory, Department of Research, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan.
Förderung
- Keio University
- School of Medicine, Keio University
Zitieren
APA
Maruiwa, Y., Niki, Y., Mabuchi, Y., Takeuchi, O., Kuronuma, S., Fukuda, Y., Fujie, A., Oya, A., Kobayashi, S., & Nakamura, M. (2026). Extracellular vesicles derived from adipose-derived mesenchymal stem/stromal cells prevent synovial inflammation and attenuate cartilage degeneration in rodent osteoarthritis. Regenerative Therapy, 31, 101056. https://doi.org/10.1016/j.reth.2025.101056
Vancouver
Maruiwa Y, Niki Y, Mabuchi Y, Takeuchi O, Kuronuma S, Fukuda Y, et al. Extracellular vesicles derived from adipose-derived mesenchymal stem/stromal cells prevent synovial inflammation and attenuate cartilage degeneration in rodent osteoarthritis. Regenerative Therapy. 2026;31:101056. doi:10.1016/j.reth.2025.101056
BibTeX
@article{Maruiwa2026,
author = {Maruiwa, Yushi and Niki, Yasuo and Mabuchi, Yo and Takeuchi, Osamu and Kuronuma, Satoshi and Fukuda, Yoshitsugu and Fujie, Atsuhiro and Oya, Akihito and Kobayashi, Shu and Nakamura, Masaya},
title = {Extracellular vesicles derived from adipose-derived mesenchymal stem/stromal cells prevent synovial inflammation and attenuate cartilage degeneration in rodent osteoarthritis},
journal = {Regenerative Therapy},
year = {2026},
volume = {31},
pages = {101056},
doi = {10.1016/j.reth.2025.101056}
}
EUVIMED